ABBV
Price
$182.38
Change
-$4.41 (-2.36%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
322.43B
28 days until earnings call
LLY
Price
$775.34
Change
-$19.78 (-2.49%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
739.66B
40 days until earnings call
Interact to see
Advertisement

ABBV vs LLY

Header iconABBV vs LLY Comparison
Open Charts ABBV vs LLYBanner chart's image
ABBVIE
Price$182.38
Change-$4.41 (-2.36%)
Volume$204.02K
Capitalization322.43B
Eli Lilly & Co
Price$775.34
Change-$19.78 (-2.49%)
Volume$12.09K
Capitalization739.66B
ABBV vs LLY Comparison Chart in %
Loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABBV vs. LLY commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a Buy and LLY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ABBV: $182.31 vs. LLY: $775.45)
Brand notoriety: ABBV and LLY are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 368% vs. LLY: 97%
Market capitalization -- ABBV: $322.43B vs. LLY: $739.66B
ABBV [@Pharmaceuticals: Major] is valued at $322.43B. LLY’s [@Pharmaceuticals: Major] market capitalization is $739.66B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 3 FA rating(s) are green whileLLY’s FA Score has 2 green FA rating(s).

  • ABBV’s FA Score: 3 green, 2 red.
  • LLY’s FA Score: 2 green, 3 red.
According to our system of comparison, ABBV is a better buy in the long-term than LLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 5 TA indicator(s) are bullish while LLY’s TA Score has 6 bullish TA indicator(s).

  • ABBV’s TA Score: 5 bullish, 4 bearish.
  • LLY’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ABBV is a better buy in the short-term than LLY.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а -1.61% price change this week, while LLY (@Pharmaceuticals: Major) price change was +1.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.72%. For the same industry, the average monthly price growth was +3.51%, and the average quarterly price growth was +7.73%.

Reported Earning Dates

ABBV is expected to report earnings on Jul 25, 2025.

LLY is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.72% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LLY($740B) has a higher market cap than ABBV($322B). LLY has higher P/E ratio than ABBV: LLY (131.13) vs ABBV (66.46). ABBV YTD gains are higher at: 4.519 vs. LLY (0.826). ABBV has higher annual earnings (EBITDA): 17.2B vs. LLY (8.57B). ABBV has more cash in the bank: 12.8B vs. LLY (2.93B). LLY has less debt than ABBV: LLY (25.2B) vs ABBV (59.4B). ABBV has higher revenues than LLY: ABBV (54.3B) vs LLY (34.1B).
ABBVLLYABBV / LLY
Capitalization322B740B44%
EBITDA17.2B8.57B201%
Gain YTD4.5190.826547%
P/E Ratio66.46131.1351%
Revenue54.3B34.1B159%
Total Cash12.8B2.93B437%
Total Debt59.4B25.2B236%
FUNDAMENTALS RATINGS
ABBV vs LLY: Fundamental Ratings
ABBV
LLY
OUTLOOK RATING
1..100
7321
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
1210
SMR RATING
1..100
1415
PRICE GROWTH RATING
1..100
5452
P/E GROWTH RATING
1..100
1595
SEASONALITY SCORE
1..100
3050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LLY's Valuation (83) in the Pharmaceuticals Major industry is in the same range as ABBV (85). This means that LLY’s stock grew similarly to ABBV’s over the last 12 months.

LLY's Profit vs Risk Rating (10) in the Pharmaceuticals Major industry is in the same range as ABBV (12). This means that LLY’s stock grew similarly to ABBV’s over the last 12 months.

ABBV's SMR Rating (14) in the Pharmaceuticals Major industry is in the same range as LLY (15). This means that ABBV’s stock grew similarly to LLY’s over the last 12 months.

LLY's Price Growth Rating (52) in the Pharmaceuticals Major industry is in the same range as ABBV (54). This means that LLY’s stock grew similarly to ABBV’s over the last 12 months.

ABBV's P/E Growth Rating (15) in the Pharmaceuticals Major industry is significantly better than the same rating for LLY (95). This means that ABBV’s stock grew significantly faster than LLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVLLY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
41%
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 16 days ago
56%
Bullish Trend 2 days ago
69%
Declines
ODDS (%)
Bearish Trend 11 days ago
46%
Bearish Trend 8 days ago
52%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
55%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WHR96.170.72
+0.75%
Whirlpool Corp
APH97.670.69
+0.71%
Amphenol Corp
SGML4.61-0.05
-1.07%
Sigma Lithium Corp
AEHR12.52-0.23
-1.80%
Aehr Test Systems
VRCA0.52-0.06
-10.28%
Verrica Pharmaceuticals

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
-2.40%
PFE - ABBV
54%
Loosely correlated
-0.21%
AMGN - ABBV
48%
Loosely correlated
-0.71%
NVS - ABBV
45%
Loosely correlated
-0.26%
JNJ - ABBV
44%
Loosely correlated
+0.26%
GILD - ABBV
43%
Loosely correlated
+2.83%
More

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-2.47%
AZN - LLY
46%
Loosely correlated
-0.33%
NVS - LLY
42%
Loosely correlated
-0.26%
OGN - LLY
39%
Loosely correlated
-1.40%
MRK - LLY
33%
Poorly correlated
+0.34%
PFE - LLY
32%
Poorly correlated
-0.21%
More